National trial launched to test re-pu... - Lung Conditions C...

Lung Conditions Community Forum

55,270 members66,033 posts

National trial launched to test re-purposing existing drugs to treat COVID-19 patients.

2greys profile image
1 Reply

A new trial to prevent organ failure and death in COVID-19 patients has been launched, led by clinicians and scientists in Cambridge and London.

TACTIC, as the trial is known, will test whether re-purposing existing drugs, which target the body’s own immune response, can prevent people suffering severe organ failure or death. The trial is part of the coordinated national approach by the UK Government to support the early phase development of potential new treatments for COVID-19.

For the majority of people with COVID-19, the infection causes only mild symptoms, including a fever and cough. However, around 15% of patients develop severe disease, including serious damage to the lungs and multiple organ failure, and about two percent die.

cam.ac.uk/research/news/nat...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
1 Reply
katieoxo60 profile image
katieoxo60

Hi 2greys, that sounds like a possible progress in respect of the virus. With the prospect of maybe reducing deaths attributed to organ failure. In fact maybe it might work for other diseases that attack our organs so could be a sign of hope for future generations, as research takes a long time to come to safe fruition that allows administration of drugs. Hope you are keeping well and thank you for all your links .

You may also like...

Study finds over 80 percent of COVID-19 patients have vitamin D deficiency.

was more prevalent in men. Over 80 percent of 200 COVID-19 patients in a hospital in Spain have...

Has anyone had a Spirometry test recently?

COPD as a result of Covid, but they weren't doing spirometry tests due to Covid. I have had a...